Weili Medical (603309.SH) sales were pre-reduced. Net profit due to mother is expected to be 75 million yuan to 95 million yuan in 2025, a decrease of 66% to 57% over the previous year

Zhitong Finance App News, Weili Medical (603309.SH) announced that the company expects to achieve net profit attributable to owners of the parent company of 75 million yuan to 95 million yuan in 2025, a decrease of 66% to 57% over the previous year.

During the reporting period, Jiangxi Langhe Medical Devices Co., Ltd. (“Wolfe Medical” for short), a wholly-owned subsidiary of the company, experienced a sharp decline in business performance due to a slowdown in product market demand growth and fierce competition in the industry. The company acquired 100% of Wolf and Healthcare's shares in 2018, forming a goodwill of 269.367 million yuan. Based on the current business situation of Wolf and Medical and the analysis and forecast of its future business situation, the company's management made a preliminary judgment that the goodwill formed by the acquisition of the company has shown signs of impairment. In order to more objectively and fairly reflect the company's financial situation and asset value, according to relevant accounting policy regulations such as “Accounting Standard for Enterprises No. 8 - Asset Impairment”, and in accordance with the principle of prudence, the company is expected to calculate an impairment of goodwill of 147 million yuan in 2025. The final amount of impairment will be determined by the evaluation agency and auditing agency hired by the company after evaluation and audit.